Found 874 matching trials
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) PHASE4 This is an efficacy and safety study to compare aprepitant with ondansetron...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Dexamethasone as an Adjuvant to Bupivacaine in Bilateral Erector Spinae Block on Postoperative Pain and Diaphragmatic Function After Pediatric Cardiac Surgeries : A Randomized Controlled Clinical Trial NA The aim of this study is to figure out the efficacy of dexamethasone additi...
Show More Location
Multiple Locations
Learn More & Join Trial
Volume vs Concentration: Quadratus Lumborum Blocks With High Volume/Low Concentration or Low Volume/ High Concentration in Nephrectomies PHASE4 The quadratus lumborum has since 2016 become standard of care for abdominal...
Show More Location
UPMC shadyside hospital
Learn More & Join Trial
A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma PHASE2 The purpose of this study is to determine efficacy of treatment with bortez...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma PHASE1 The purpose of the Phase 1 part of the study is to determine the maximum to...
Show More Location
California Cancer Associates For Research and Exellence, cCare
Learn More & Join Trial
Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery. PHASE4 The purpose of this study is to determine if there is a difference in patie...
Show More Location
Hospital for Special Surgery, New York
Learn More & Join Trial
Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma PHASE2 Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma PHASE2 Study Objectives
1. Evaluate the efficacy of the combination of thalidomid...
Show More Location
Weill Medical College of Cornell University
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT PHASE2 Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Show More Location
Hospital Universitario Son Espases
Learn More & Join Trial